UNLABELLED: Angiographic Perfusion Score (APS) proposed as a simple, angiographic score linking epicardial and myocardial perfusion parameters before and after percutaneous coronary intervention (PCI) is a predictor of short-term outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with PCI. Aim of the study was to analyze the correlation between APS and both infarct size and left ventricular function in long-term follow-up. In a cohort of 68 patients with STEMI treated with PCI APS was calculated for infarct-related artery based on angiographic parameters and was defined as the sum of the Thrombolysis in Myocardial Infarction (TIMI) flow grade (0-3 points) and the TIMI myocardial perfusion grade (0-3 points) before and after PCI (range of points from 0 to 12). Full perfusion was defined as APS ≥ 10. Cardiac magnetic resonance (CMR) parameters and N-terminal pro-brain natriuretic peptide (NT pro-BNP) were assessed at 6 months. RESULTS: Median APS was 7.5 points. APS ≥ 10 was present in 42% of patients. The significant correlation was found between APS and: CMR infarct size (r = - 0.48; P = 0.0001), CMR left ventricular (LV) ejection fraction (r = 0.5; P = 0.002), LV end-diastolic volume index (r = - 0.37; P = 0.004), LV end-systolic volume index (r = -0.41; P = 0.001), NT pro-BNP (r = - 0.5; P = 0.02). Patients with APS ≥ 10 had significantly lower infarct size, LV volumes, higher EF and lower NT pro-BNP. APS assessed in patients with STEMI treated with PCI is a good predictor of infarct size and left ventricular function in 6-month follow-up.
UNLABELLED: Angiographic Perfusion Score (APS) proposed as a simple, angiographic score linking epicardial and myocardial perfusion parameters before and after percutaneous coronary intervention (PCI) is a predictor of short-term outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with PCI. Aim of the study was to analyze the correlation between APS and both infarct size and left ventricular function in long-term follow-up. In a cohort of 68 patients with STEMI treated with PCI APS was calculated for infarct-related artery based on angiographic parameters and was defined as the sum of the Thrombolysis in Myocardial Infarction (TIMI) flow grade (0-3 points) and the TIMI myocardial perfusion grade (0-3 points) before and after PCI (range of points from 0 to 12). Full perfusion was defined as APS ≥ 10. Cardiac magnetic resonance (CMR) parameters and N-terminal pro-brain natriuretic peptide (NT pro-BNP) were assessed at 6 months. RESULTS: Median APS was 7.5 points. APS ≥ 10 was present in 42% of patients. The significant correlation was found between APS and: CMR infarct size (r = - 0.48; P = 0.0001), CMR left ventricular (LV) ejection fraction (r = 0.5; P = 0.002), LV end-diastolic volume index (r = - 0.37; P = 0.004), LV end-systolic volume index (r = -0.41; P = 0.001), NT pro-BNP (r = - 0.5; P = 0.02). Patients with APS ≥ 10 had significantly lower infarct size, LV volumes, higher EF and lower NT pro-BNP. APS assessed in patients with STEMI treated with PCI is a good predictor of infarct size and left ventricular function in 6-month follow-up.
Authors: C M Gibson; C P Cannon; S A Murphy; K A Ryan; R Mesley; S J Marble; C H McCabe; F Van De Werf; E Braunwald Journal: Circulation Date: 2000-01-18 Impact factor: 29.690
Authors: Elliott M Antman; Mary Hand; Paul W Armstrong; Eric R Bates; Lee A Green; Lakshmi K Halasyamani; Judith S Hochman; Harlan M Krumholz; Gervasio A Lamas; Charles J Mullany; David L Pearle; Michael A Sloan; Sidney C Smith; Daniel T Anbe; Frederick G Kushner; Joseph P Ornato; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy Journal: Circulation Date: 2007-12-10 Impact factor: 29.690
Authors: G W Stone; D Cox; E Garcia; B R Brodie; M C Morice; J Griffin; L Mattos; A J Lansky; W W O'Neill; C L Grines Journal: Circulation Date: 2001-08-07 Impact factor: 29.690
Authors: Dariusz Dudek; Tomasz Rakowski; Nader El Massri; Danuta Sorysz; Jaroslaw Zalewski; Jacek Legutko; Artur Dziewierz; Lukasz Rzeszutko; Krzysztof Zmudka; Wieslawa Piwowarska; Giuseppe De Luca; Grzegorz L Kaluza; Marianna Janion; Jacek S Dubiel Journal: Int J Cardiol Date: 2007-04-12 Impact factor: 4.164
Authors: Bruce R Brodie; Thomas D Stuckey; Charles Hansen; Debra S VerSteeg; Denise B Muncy; Susan Moore; Navin Gupta; William E Downey Journal: Am J Cardiol Date: 2005-02-01 Impact factor: 2.778
Authors: C Michael Gibson; Sabina A Murphy; David A Morrow; Julian M Aroesty; Raymond J Gibbons; Steven G Gourlay; Hal V Barron; Robert P Giugliano; Elliott M Antman; Eugene Braunwald Journal: Am Heart J Date: 2004-08 Impact factor: 4.749
Authors: Yuri B Pride; Jacqueline L Buros; Erin Lord; Matthew C Southard; Caitlin J Harrigan; Lauren N Ciaglo; Marc S Sabatine; Christopher P Cannon; C Michael Gibson Journal: J Thromb Thrombolysis Date: 2007-07-12 Impact factor: 2.300
Authors: Frans Van de Werf; Jeroen Bax; Amadeo Betriu; Carina Blomstrom-Lundqvist; Filippo Crea; Volkmar Falk; Gerasimos Filippatos; Keith Fox; Kurt Huber; Adnan Kastrati; Annika Rosengren; P Gabriel Steg; Marco Tubaro; Freek Verheugt; Franz Weidinger; Michael Weis Journal: Eur Heart J Date: 2008-11-12 Impact factor: 29.983